Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,139,458
New position
Shares Held
950
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#3,012
of 4,605 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannon Advisors, Inc. holds $1,477,410 across 2 Drug Manufacturers - General names. LLY ranks #1 (77.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
950 | $1,139,458 | |
| 2 | ABBV |
AbbVie Inc.
|
1,343 | $337,952 |
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,139,458 | 950 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||